Syngene updates: news & description

Presence

Syngene provides research, development, and manufacturing services for pharmaceuticals and biotechnology. Its main services include drug discovery, clinical development, and biologics manufacturing for global drug companies and healthcare customers.

Syngene products and services overview:

Drug discovery
Clinical development
Biologics manufacturing
Small molecule manufacturing
Research services
Analytical services

Revenue: ~$439 million

Employees: 5,600

Headquarters: Bengaluru, India

Syngene is owned by Biocon.

Biocon is one of the...

Biocon is a company listed under the stock ticker BIOCON (IN).

Biocon has a direct presence in 2 countries.

Biocon has 3 subsidiaries including Bicara Therapeutics, Biocon Biologics and Syngene.

They are in:

Biotechnology75%
Pharmaceuticals25%

Executives

View the org chart displaying its 42 main executives

Most searched biographies at Syngene

Popular executive movements at Syngene

Abhijit Zutshi has joined the company as Chief Commercial Officer (posted on May 4 2026).
Maninder Kapoor Puri has joined the company as Chief Human Resources Officer (posted on April 2 2026).
Siddharth Mittal will join the company as Chief Executive Officer on Jul. 1, 2026 (posted on March 30 2026).

Click here to view some more movements at Syngene

Popular executive movements at Biocon

Karthik Sm who was Head of Human Resources, Global Operations and Enabling, becomes Head of Human Resources, India, Malaysia and Emerging Markets (posted on April 22 2026).
Kedar Upadhye who is Chief Financial Officer, Combined Business, will be promoted to Chief Financial Officer on Apr. 1, 2026 (posted on March 27 2026).
Shreehas Tambe who is Chief Executive Officer, Biocon Biologics, will become Director and Chief Executive Officer, Biocon Biologics on Apr. 1, 2026 (posted on March 27 2026).

Click here to view some more movements at Biocon

Create your alert
to follow the executive moves at Syngene.